| Literature DB >> 32917253 |
Xiaoliang Liu1,2,3, Kaiyu Zhou1,2,3,4, Yimin Hua1,2,3,4, Mei Wu1,5, Lei Liu1,5, Shuran Shao1,5, Chuan Wang6,7,8,9.
Abstract
BACKGROUND: Approximately 50-70% of patients with Kawasaki disease (KD) could present with cervical lymphadenopathy associated with deep neck inflammation, which may result in Grisel's syndrome (GS). Given the possibility of neurological impairment owing to GS, it is important to understand the disease profile in KD. Therefore, we carried out this study to investigate this possible complication of KD, with the aim of improving pediatricians' recognition and awareness.Entities:
Keywords: Atlantoaxial subluxation; Cervical lymphadenopathy; Children; Coronary artery lesions; Neurological impairment
Mesh:
Year: 2020 PMID: 32917253 PMCID: PMC7488729 DOI: 10.1186/s13023-020-01535-0
Source DB: PubMed Journal: Orphanet J Rare Dis ISSN: 1750-1172 Impact factor: 4.123
The summary of Grisel’s syndrome in Kawasaki disease
| Patient | Author, country | Age(years), Sex | Duration before diagnosis | Clinical presentation | Lymphadenopathy | Fielding classification | Rotatory dislocation | Treatment | Duration treatment | CALs |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Igarashi,1989 [ | 7, F | 7 days | Tilted position | Left | – | Left | Conservative | 2 months | None |
| 2 | Kaketa, 2004 [ | 5, F | 5 months | Torticollis | – | – | Left | Conservative | 3 months | – |
| 3 | Konishi, 2007 [ | 4, F | 11 days | Torticollis | Left | Type I | Left | Conservative | 13 days | – |
| 4 | Konishi, 2007 [ | 4, F | 4 days | Torticollis | Left | Type I | Left | Conservative | 8 days | – |
| 5 | Oda, 2009 [ | 9, M | 13 days | Torticollis | Right | Type I | Right | Conservative | 3 days | None |
| 6 | Oda, 2009 [ | 6, F | 15 days | Torticollis | Right | Type I | Right | Conservative | 15 days | None |
| 7 | Oda, 2009 [ | 6, M | 14 days | Torticollis | Bilateral | Type I | Left | Conservative | 7 days | None |
| 8 | Tashiro, 2011 [ | 6, F | 3 days | – | – | – | Right | Conservative | – | – |
| 9 | Nozaki, 2013 [ | 5, F | 22 days | Tilted position | Left | Type I | Left | Conservative | 2 months | None |
| 10 | Wood [ | 8, F | 8 days | Torticollis Neck pain and stiffness | Left | – | Left | Conservative | 3 months | None |
| 11 | Tian LP [ | 6, F | 9 days | Torticollis Neck pain and stiffness, | Bilateral | Type I | Left | Conservative | 25 days | None |
| 12 | Wang Ce, 2018 [ | 5, M | – | Neck pain and stiffness, | – | – | – | Conservative | 3 days | None |
| 13 | Wang Ce, 2018 [ | 5, M | – | Neck pain and stiffness | – | – | – | Conservative | 6 days | None |
| 14 | Wang Ce, 2018 [ | 5, M | – | Neck pain and stiffness | – | – | – | Conservative | 7 days | None |
Fig. 1An axial computed tomography (CT) scan shows atlantoaxial rotatory subluxation (a and b). A three-dimensional CT scan showing subluxation of the C1-C2 cervical tract (c)
The clinical characteristics of Grisel’s syndrome in patients with Kawasaki disease
| Patient | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Age(years), Sex | 6.6, F | 5.7, M | 3.7, F | 7.2, F | 6.3, F | 6.2, M | 7.3, F | 3.5, F | 4.5, F | 5.2, F |
| Initial admitted Department | Neurology | Surgeon | Cardiology | Cardiology | Surgeon | Cardiology | Cardiology | Cardiology | Cardiology | Cardiology |
| Primary diagnosis | Lymphnoditis, Aseptic meningitis | Lymphnoditis | Lymphnoditis | Lymphnoditis | Lymphnoditis, GS | Lymphnoditis, GS | Lymphnoditis | Lymphnoditis | Tonsillitis | Lymphnoditis |
| Days before the diagnosis of GS | 5 | 5 | 2 | 6 | 4 | 8 | 10 | 4 | 7 | 8 |
| Days before the diagnosis of KD | 7 | 8 | 5 | 6 | 5 | 8 | 6 | 6 | 7 | 6 |
| Fever days before IVIG treatment | 7 | 9 | 5 | 6 | 6 | 9 | 7 | 6 | 9 | 7 |
| Principal clinical features of KD | 1, 2, 3, 6 | 1, 2, 5, 6 | 1, 3, 5, 6 | 1,3, 6 | 2, 3, 6 | 1,2,3,4, 6 | 1,2,3,5,6 | 1,2,3,4,5,6 | 1, 2, 4, 5, 6 | 1, 2, 3, 6 |
| Incomplete KD | + | + | + | + | + | – | – | – | – | + |
| IVIG resistance | – | – | – | – | – | – | – | – | – | – |
| CALs | – | – | – | – | – | – | – | – | – | – |
| Torticollis/Neck pain | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/+ | +/− |
| Lymphadenopathy, size(mm) | Ra, 4.5*5.0 | La, 2.5*2.5 | L, 3.5*3.0 | L, 2.0*2.0 | L, 1.5*2.0 | L, 1.5*2.5 | R, 1.9*3.6 | L, 1.8*2.7 | R, 2.5*1.6 | L, 3.0*4.0 |
| Fielding classification | Type I | Type III | Type I | Type I | Type III | Type II | Type II | Type I | Type III | Type III |
| Rotatory dislocation | Right | Left | Left | Left | Right | Left | Left | Left | Left | Left |
| Treatment | Conservative | Conservative | Conservative | Conservative | Conservative | Conservative | Conservative | Conservative | Conservative | Conservative |
| Duration treatment | 1 month | 2 months | 14 days | 7 days | 1.5 months | 21 days | 21 days | 7 days | 3 months | 2.5 months |
Principal clinical features of KD:1. Fever for at least 5 days; 2. Bilateral bulbar conjunctival injection without exudate; 3. Changes in lips and oral cavity;4. Changes in extremities; 5. Polymorphous exanthem; 6. Cervical lymphadenopathy
aR, right side; L, left side
Comparison of clinical data between the groups of Kawasaki disease (KD) with and without Grisel syndrome (GS)
| KD with GS | KD without GS | ||
|---|---|---|---|
| Male, n (%) | 2(20.0) | 731(58.3) | 0.021 |
| Age, years | 5.9(4.3–6.7) | 2.2(1.2–3.6) | <0.001 |
| Rash | 5(50.0) | 939(74.9) | 0.134 |
| Edema & erythema of the extremities | 3(30.0) | 715(57.0) | 0.111 |
| Bilateral bulbar conjunctive injection | 8(80.0) | 1138(90.7) | 0.226 |
| Erythema of oral and pharyngeal mucosa | 8(80.0) | 1142 (91.1) | 0.256 |
| Cervical lymphadenopathy | 10(100.0) | 647(51.6) | 0.002 |
| Fever duration before IVIG administration, days | 6.0(4.8–7.3) | 6.0(5.0–7.0) | 0.916 |
| Incomplete KD | 6(60.0) | 460(36.7) | 0.186 |
| IVIG resistance | 0(0.00) | 188(15.0) | 0.374 |
| Coronary artery lesions | 0(0.00) | 125(10.6) | 0.292 |
| White blood cell, ×109/L | 14.6(12.5–18.8) | 14.0(11.0–17.4) | 0.744 |
| Neutrophil count, % | 79.9(77.2–91.7) | 68.3(58.0–78.6) | 0.001 |
| Hemoglobin, g/L | 108.0(99.3–117.5) | 109.0(102.0–116.0) | 0.737 |
| Platelet count, ×109/L | 313(268–350) | 325(267–395) | 0.344 |
| C-reactive protein, mg/L | 111.0(69.5–155.5) | 76.0(45.0–114.0) | 0.155 |
| Erythrocyte sedimentation rate, mm/h | 102.0(59.0–124.0) | 66.0(46.0–87.0) | 0.018 |
| Aspartate aminotransferase, U/L | 34.5(27.0–56.5) | 34.0(26.0–52.0) | 0.573 |
| Alanine aminotransferase, U/L | 25.5(13.0–39.0) | 37.0(21.0–79.0) | 0.332 |
| Albumin, g/L | 36.0(31.7–42.3) | 37.5(34.1–40.9) | 0.667 |
| Total bilirubin, umol/L | 9.2(7.1–15.5) | 6.3(4.0–10.0) | 0.858 |
| Creatinine, umol/L | 30.0(25.0–41.5) | 28.0(23.0–33.0) | 0.839 |
| Urea nitrogen, umol/L | 2.7(2.3–4.9) | 2.9(2.2–4.0) | 0.429 |
| Serum sodium, mmol/L | 138.2(135.1–138.2) | 136.9(134.0–139.0) | 0.880 |
| Potassium, mmol/L | 4.0(3.7–4.1) | 4.1(3.7–4.5) | 0.396 |
The data are presented as the median with the 25th and 75th percentiles in square brackets for continuous variables and as n/% for qualitative data as appropriate